Angel dust: possible effects on the fetus

Pediatrics
|January 1, 1980
PubMed

Insights

This case report details an infant exposed to phencyclidine (PCP) during pregnancy, exhibiting abnormal neonatal behavior, dysmorphology, and spastic quadriparesis. Further research is needed to confirm the link between prenatal PCP exposure and these developmental outcomes.

Area of Science:

  • Neonatal Abstinence Syndrome
  • Developmental Toxicology
  • Neurodevelopmental Disorders

Background:

  • Prenatal exposure to substances of abuse is a significant concern.
  • Phencyclidine (PCP), a dissociative anesthetic, has known neurotoxic effects.
  • Limited data exists on the long-term effects of prenatal PCP exposure in humans.

Observation:

  • A neonate presented with abnormal behavior and dysmorphology after maternal phencyclidine (PCP) use during pregnancy.
  • The infant later developed spastic quadriparesis.
  • Neonatal behaviors were consistent with known effects of PCP.

Findings:

  • The infant likely experienced prolonged fetal exposure to PCP.
  • A potential association between prenatal PCP exposure and the infant's dysmorphology and spasticity is suggested.
  • The precise relationship remains speculative and requires further investigation.

Implications:

  • Clinicians should be vigilant for similar presentations in infants with prenatal PCP exposure.
  • This case highlights the potential teratogenic effects of PCP.
  • Further research is warranted to elucidate the full spectrum of developmental outcomes associated with prenatal PCP exposure.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Allergic Reactions02:06

Allergic Reactions

Overview
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...